Left Kidney Undifferentiated Spindle Cell Sarcoma with Myeloid Cell Leukemia-1 Amplification: Therapeutic Response to Bortezomib, Venetoclax, and Dexamethasone Therapy
The overexpression of myeloid cell leukemia-1 (MCL-1) has been identified in numerous hematologic malignancies and solid tumors. Currently, there are no selective MCL-1 inhibitors. Here, we present a case of left kidney undifferentiated spindle cell sarcoma with MCL-1 amplification. The tumor showed...
| الحاوية / القاعدة: | Journal of Cancer Research and Practice |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Wolters Kluwer Medknow Publications
2023-10-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-23-00026 |